Buckley Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-56,067
Closed -$3.46M 109
2022
Q3
$3.46M Sell
56,067
-11,120
-17% -$701K 1.27% 22
2022
Q2
$4.15M Sell
67,187
-5,605
-8% -$347K 1.34% 21
2022
Q1
$4.33M Buy
72,792
+7,053
+11% +$451K 1.17% 22
2021
Q4
$4.77M Sell
65,739
-1,223
-2% -$84.2K 1.39% 20
2021
Q3
$4.68M Sell
66,962
-638
-0.9% -$44.8K 1.51% 20
2021
Q2
$4.66M Sell
67,600
-445
-0.7% -$29.7K 1.6% 20
2021
Q1
$4.4M Buy
68,045
+3,736
+6% +$241K 1.63% 18
2020
Q4
$3.75M Buy
64,309
+10,917
+20% +$659K 1.54% 17
2020
Q3
$3.37M Buy
53,392
+24,690
+86% +$1.71M 1.51% 18
2020
Q2
$2.21M Buy
28,702
+40
+0.1% +$3.06K 1% 23
2020
Q1
$2.14M Buy
28,662
+1,508
+6% +$104K 1.16% 23
2019
Q4
$1.76M Sell
27,154
-6,952
-20% -$453K 0.8% 24
2019
Q3
$2.16M Buy
34,106
+211
+0.6% +$13.8K 1.06% 24
2019
Q2
$2.29M Buy
33,895
+1,663
+5% +$109K 1.07% 24
2019
Q1
$2.1M Buy
32,232
+2,574
+9% +$171K 0.99% 24
2018
Q4
$1.85M Buy
29,658
+465
+2% +$32.5K 0.96% 25
2018
Q3
$2.25M Buy
29,193
+180
+0.6% +$13.6K 0.98% 27
2018
Q2
$2.06M Sell
29,013
-690
-2% -$48.7K 0.97% 27
2018
Q1
$2.24M Sell
29,703
-223
-0.7% -$17.7K 1.11% 26
2017
Q4
$2.14M Buy
+29,926
New +$2.27M 1.08% 25

Other funds holding GILD

Buckley Wealth Management's GILD Position: Q4 2022 in Review

Buckley Wealth Management sold out of Gilead Sciences (GILD) in Q4 2022, closing a stake of 56,067 shares — an estimated $3.46M sold.

Buckley Wealth Management first reported a position in GILD in Q4 2017 and held it in 20 quarters. The position peaked at $4.77M in Q4 2021. 1,768 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

  • Buckley Wealth Management reported no remaining Gilead Sciences position as of Q4 2022 after selling out during the quarter.
  • Buckley Wealth Management sold 56,067 Gilead Sciences shares in Q4 2022, an estimated $3.46M.
  • Buckley Wealth Management first reported a position in Gilead Sciences in Q4 2017 and held it in 20 quarters.
  • Buckley Wealth Management's Gilead Sciences position peaked at $4.77M in Q4 2021.
  • 1,768 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on Buckley Wealth Management's 13F filing for Q4 2022, filed 10 Feb 2023.